Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 20,000 shares at $29.88 ($588K) on 2014-08-04, disclosed to the SEC on 2014-08-05.
Scheduled sale ($588k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.08 | 11,573 | $337K | 57.2% |
| 2 | $29.88 | 8,427 | $252K | 42.8% |
| Total | $29.42 avg | 20,000 | $588K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |